免疫疗法：克隆性新抗原与免疫反应：一场平衡行动。 - Suppr

Suppr

超能文献

Immunotherapy: Clonal neoantigens and immune response: a balancing act.

作者信息

Hutchinson Lisa

出版信息

Nat Rev Clin Oncol. 2016 May;13(5):265. doi: 10.1038/nrclinonc.2016.49. Epub 2016 Mar 31.

DOI:10.1038/nrclinonc.2016.49

PMID:27030076

Abstract

摘要

相似文献

Immunotherapy: Clonal neoantigens and immune response: a balancing act.

Nat Rev Clin Oncol. 2016 May;13(5):265. doi: 10.1038/nrclinonc.2016.49. Epub 2016 Mar 31.

Cancer Neoantigens and Applications for Immunotherapy.

Clin Cancer Res. 2016 Feb 15;22(4):807-12. doi: 10.1158/1078-0432.CCR-14-3175. Epub 2015 Oct 29.

Study May Change Approach to Immunotherapy.

Cancer Discov. 2016 May;6(5):OF1. doi: 10.1158/2159-8290.CD-NB2016-034. Epub 2016 Mar 24.

Targeting neoantigens to augment antitumour immunity.

Nat Rev Cancer. 2017 Apr;17(4):209-222. doi: 10.1038/nrc.2016.154. Epub 2017 Feb 24.

Characterizing neoantigens for personalized cancer immunotherapy.

Curr Opin Immunol. 2017 Jun;46:58-65. doi: 10.1016/j.coi.2017.04.007. Epub 2017 May 4.

Targeting Neoantigens for Personalised Immunotherapy.

BioDrugs. 2018 Apr;32(2):99-109. doi: 10.1007/s40259-018-0267-4.

The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer.

Adv Immunol. 2016;130:25-74. doi: 10.1016/bs.ai.2016.01.001. Epub 2016 Feb 10.

Links between genetics and immunology: mutations and antigens.

Bull Acad Natl Med. 2016 Jan;200(1):67-79.

Personalized T cell-mediated cancer immunotherapy: progress and challenges.

Curr Opin Biotechnol. 2017 Dec;48:142-152. doi: 10.1016/j.copbio.2017.03.024. Epub 2017 May 8.

The role of neoantigens in response to immune checkpoint blockade.

Int Immunol. 2016 Aug;28(8):411-9. doi: 10.1093/intimm/dxw019. Epub 2016 Apr 5.

引用本文的文献

Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer.

Mol Cancer. 2021 Feb 23;20(1):37. doi: 10.1186/s12943-021-01331-9.

Engineering chimeric antigen receptor-T cells for cancer treatment.

Mol Cancer. 2018 Feb 15;17(1):32. doi: 10.1186/s12943-018-0814-0.

Cancer vaccine: learning lessons from immune checkpoint inhibitors.

J Cancer. 2018 Jan 1;9(2):263-268. doi: 10.7150/jca.20059. eCollection 2018.

Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies.

J Immunol Res. 2017;2017:5210459. doi: 10.1155/2017/5210459. Epub 2017 Jan 2.

本文引用的文献

Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade.

Science. 2016 Mar 25;351(6280):1463-9. doi: 10.1126/science.aaf1490. Epub 2016 Mar 3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Immunotherapy: Clonal neoantigens and immune response: a balancing act.

Nat Rev Clin Oncol. 2016 May;13(5):265. doi: 10.1038/nrclinonc.2016.49. Epub 2016 Mar 31.

Cancer Neoantigens and Applications for Immunotherapy.

Clin Cancer Res. 2016 Feb 15;22(4):807-12. doi: 10.1158/1078-0432.CCR-14-3175. Epub 2015 Oct 29.

Study May Change Approach to Immunotherapy.

Cancer Discov. 2016 May;6(5):OF1. doi: 10.1158/2159-8290.CD-NB2016-034. Epub 2016 Mar 24.

Targeting neoantigens to augment antitumour immunity.

Nat Rev Cancer. 2017 Apr;17(4):209-222. doi: 10.1038/nrc.2016.154. Epub 2017 Feb 24.

Characterizing neoantigens for personalized cancer immunotherapy.

Curr Opin Immunol. 2017 Jun;46:58-65. doi: 10.1016/j.coi.2017.04.007. Epub 2017 May 4.

Targeting Neoantigens for Personalised Immunotherapy.

BioDrugs. 2018 Apr;32(2):99-109. doi: 10.1007/s40259-018-0267-4.

The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer.

Adv Immunol. 2016;130:25-74. doi: 10.1016/bs.ai.2016.01.001. Epub 2016 Feb 10.

Links between genetics and immunology: mutations and antigens.

Bull Acad Natl Med. 2016 Jan;200(1):67-79.

Personalized T cell-mediated cancer immunotherapy: progress and challenges.

Curr Opin Biotechnol. 2017 Dec;48:142-152. doi: 10.1016/j.copbio.2017.03.024. Epub 2017 May 8.

The role of neoantigens in response to immune checkpoint blockade.

Int Immunol. 2016 Aug;28(8):411-9. doi: 10.1093/intimm/dxw019. Epub 2016 Apr 5.

引用本文的文献

Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer.

Mol Cancer. 2021 Feb 23;20(1):37. doi: 10.1186/s12943-021-01331-9.

Engineering chimeric antigen receptor-T cells for cancer treatment.

Mol Cancer. 2018 Feb 15;17(1):32. doi: 10.1186/s12943-018-0814-0.

Cancer vaccine: learning lessons from immune checkpoint inhibitors.

J Cancer. 2018 Jan 1;9(2):263-268. doi: 10.7150/jca.20059. eCollection 2018.

Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies.

J Immunol Res. 2017;2017:5210459. doi: 10.1155/2017/5210459. Epub 2017 Jan 2.

本文引用的文献

Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade.

Science. 2016 Mar 25;351(6280):1463-9. doi: 10.1126/science.aaf1490. Epub 2016 Mar 3.